Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1050184

Enhancing pharmacovigilance capabilities in the EU regulatory network: the scope joint action


Radecka, Anna; Loughlin, Louise; Foy, Mick; de Ferraz Guimaraes, Margarida Viana; Macolić Šarinić, Viola; Dimov di Giusti, Marina; Lesičar, Marina; Straus, Sabine; Montero, Dolores; Pallos, Julia et al.
Enhancing pharmacovigilance capabilities in the EU regulatory network: the scope joint action // Drug safety, 41 (2018), 12; 1285-1302 doi:10.1007/s40264-018-0708-5 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1050184 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Enhancing pharmacovigilance capabilities in the EU regulatory network: the scope joint action

Autori
Radecka, Anna ; Loughlin, Louise ; Foy, Mick ; de Ferraz Guimaraes, Margarida Viana ; Macolić Šarinić, Viola ; Dimov di Giusti, Marina ; Lesičar, Marina ; Straus, Sabine ; Montero, Dolores ; Pallos, Julia ; Ivanović, Jelena ; Raine, June

Izvornik
Drug safety (0114-5916) 41 (2018), 12; 1285-1302

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
pharmacovigilance ; European Union ; risk assessment ; drug industry

Sažetak
In November 2013, a team of European regulators initiated the Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) Joint Action. Funded by the Health Programme of the European Union, and with contributions from the involved Member States, SCOPE gathered information and expertise on how regulators in Member States run their national pharmacovigilance systems to meet the requirements of the pharmacovigilance legislation that came into effect in June 2012. The SCOPE project evaluated then-current practices and developed tools to further improve the skills and capability in the pharmacovigilance network. The project was divided into eight separate work streams, five of which concentrated on pharmacovigilance topicscollecting information on suspected adverse drug reactions, identifying and managing safety issues (signals), communicating risk and assessing risk minimisation measures, supported by effective quality management systems. The other three work streams focused on the functional aspectscoordination, communication and evaluation of the project. Through the project, SCOPE delivered guidance, training in key aspects of pharmacovigilance, and tools and templates to support best practice. The deliverables provide practical guidance that those working in the European national competent authorities can take to strengthen their national systems. The SCOPE outputs can be useful for other stakeholders involved in pharmacovigilance activities, including the pharmaceutical industry, healthcare professionals, patient and consumer organisations, and academia

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Javno zdravstvo i zdravstvena zaštita



POVEZANOST RADA


Poveznice na cjeloviti tekst rada:

doi link.springer.com

Citiraj ovu publikaciju:

Radecka, Anna; Loughlin, Louise; Foy, Mick; de Ferraz Guimaraes, Margarida Viana; Macolić Šarinić, Viola; Dimov di Giusti, Marina; Lesičar, Marina; Straus, Sabine; Montero, Dolores; Pallos, Julia et al.
Enhancing pharmacovigilance capabilities in the EU regulatory network: the scope joint action // Drug safety, 41 (2018), 12; 1285-1302 doi:10.1007/s40264-018-0708-5 (međunarodna recenzija, članak, znanstveni)
Radecka, A., Loughlin, L., Foy, M., de Ferraz Guimaraes, M., Macolić Šarinić, V., Dimov di Giusti, M., Lesičar, M., Straus, S., Montero, D. & Pallos, J. (2018) Enhancing pharmacovigilance capabilities in the EU regulatory network: the scope joint action. Drug safety, 41 (12), 1285-1302 doi:10.1007/s40264-018-0708-5.
@article{article, author = {Radecka, Anna and Loughlin, Louise and Foy, Mick and de Ferraz Guimaraes, Margarida Viana and Macoli\'{c} \v{S}arini\'{c}, Viola and Dimov di Giusti, Marina and Lesi\v{c}ar, Marina and Straus, Sabine and Montero, Dolores and Pallos, Julia and Ivanovi\'{c}, Jelena and Raine, June}, year = {2018}, pages = {1285-1302}, DOI = {10.1007/s40264-018-0708-5}, keywords = {pharmacovigilance, European Union, risk assessment, drug industry}, journal = {Drug safety}, doi = {10.1007/s40264-018-0708-5}, volume = {41}, number = {12}, issn = {0114-5916}, title = {Enhancing pharmacovigilance capabilities in the EU regulatory network: the scope joint action}, keyword = {pharmacovigilance, European Union, risk assessment, drug industry} }
@article{article, author = {Radecka, Anna and Loughlin, Louise and Foy, Mick and de Ferraz Guimaraes, Margarida Viana and Macoli\'{c} \v{S}arini\'{c}, Viola and Dimov di Giusti, Marina and Lesi\v{c}ar, Marina and Straus, Sabine and Montero, Dolores and Pallos, Julia and Ivanovi\'{c}, Jelena and Raine, June}, year = {2018}, pages = {1285-1302}, DOI = {10.1007/s40264-018-0708-5}, keywords = {pharmacovigilance, European Union, risk assessment, drug industry}, journal = {Drug safety}, doi = {10.1007/s40264-018-0708-5}, volume = {41}, number = {12}, issn = {0114-5916}, title = {Enhancing pharmacovigilance capabilities in the EU regulatory network: the scope joint action}, keyword = {pharmacovigilance, European Union, risk assessment, drug industry} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font